Augmenix is a medical device company focused on the development and commercialization of radiation oncology and urology products using its proprietary hydrogel technology. Its solution is designed to minimize unintended radiation damage to normal organs and the accompanying side effects. Augmenix provides SpaceOAR, an absorbable hydrogel that temporarily moves the rectum away from the prostate and the high-intensity radiation zone. Additionally, the company offers an absorbable tissue marker, TraceIT.